tyrosine and Acute Relapsing Multiple Sclerosis

tyrosine has been researched along with Acute Relapsing Multiple Sclerosis in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hooper, DC; Jacobs, D; Koprowski, H; Markowitz, CE; Spitsin, S; Udupa, JK; Zimmerman, V1
Majsterek, I; Miller, E; Ponczek, MB; Saluk, J; Walczak, A1
Basic, J; Cvetkovic, T; Ilic, A; Ljubisavljevic, S; Pavlovic, D; Pavlovic, R; Stojanovic, I; Stukalov, M; Vojinovic, S1
Felaco, M; Gambi, D; Iarlori, C; Lugaresi, A; Patruno, A; Reale, M; Salvatore, M; Speranza, L1

Trials

2 trial(s) available for tyrosine and Acute Relapsing Multiple Sclerosis

ArticleYear
The treatment of multiple sclerosis with inosine.
    Journal of alternative and complementary medicine (New York, N.Y.), 2009, Volume: 15, Issue:6

    Topics: Adjuvants, Immunologic; Administration, Oral; Adult; Brain; CD4 Lymphocyte Count; Central Nervous System; Cross-Over Studies; Cytokines; Disability Evaluation; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Inosine; Kidney Calculi; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Th1 Cells; Th2 Cells; Tyrosine; Uric Acid; Young Adult

2009
Reduction of free radicals in multiple sclerosis: effect of glatiramer acetate (Copaxone).
    Multiple sclerosis (Houndmills, Basingstoke, England), 2008, Volume: 14, Issue:6

    Topics: Adult; Cells, Cultured; Female; Free Radicals; Glatiramer Acetate; Humans; Immunosuppressive Agents; Leukocytes, Mononuclear; Lipopolysaccharides; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Nitric Oxide; Nitric Oxide Synthase Type II; Oxidative Stress; Peptides; Superoxides; Tyrosine

2008

Other Studies

2 other study(ies) available for tyrosine and Acute Relapsing Multiple Sclerosis

ArticleYear
Oxidative modification of patient's plasma proteins and its role in pathogenesis of multiple sclerosis.
    Clinical biochemistry, 2012, Volume: 45, Issue:1-2

    Topics: Adult; Blood Proteins; Blood-Brain Barrier; Carbon; Disease Progression; Female; Humans; Male; Middle Aged; Models, Statistical; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Oxidative Stress; Oxygen; Reactive Oxygen Species; Tyrosine; Uric Acid

2012
INF-β1b therapy modulates L-arginine and nitric oxide metabolism in patients with relapse remittent multiple sclerosis.
    Journal of the neurological sciences, 2012, Dec-15, Volume: 323, Issue:1-2

    Topics: Adult; Arginase; Arginine; Biomarkers; Drug Monitoring; Female; Follow-Up Studies; Humans; Inflammation; Interferon beta-1b; Interferon-beta; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Nitrates; Nitric Oxide; Nitrites; Nitroso Compounds; Severity of Illness Index; Sulfhydryl Compounds; Tyrosine; Young Adult

2012